Table 1: Biomarkers retroactive follow-up.
Date | CC3 | CC4 | ESR | CRP | RF |
10/07/2010 | 34 mg/dL | 3.9 mg/dL | 13 mm | 17.8 mg/L | 40 UI/mL |
12/03/2010 | 47 mg/dL | 6.9 mg/dL | 17 mm | 10.0 mg/L | * |
10/31/2011 | 65 mg/dL | 10.0 mg/dL | 13 mm | 3.6 mg/L | * |
12/17/2012 | 24 mg/dL | 2.0 mg/dL | 21 mm | 44.2 mg/L | * |
02/18/2013 | 27 mg/dL | 3.0 mg/dL | * | 48.9 mg/L | * |
04/05/2013 | 26 mg/dL | 3.0 mg/dL | * | 13.5 mg/L | * |
05/17/2013 | 56 mg/dL | 10.0 mg/dL | * | 3.7 mg/L | * |
07/08/2013 | 36 mg/dL | 6.0 mg/dL | * | 12.1 mg/L | * |
10/03/2013 | 32 mg/dL | 4.0 mg/dL | 5 mm | 4.32 mg/L | * |
01/15/2014 | 30 mg/dL | 3.7 mg/dL | 12 mm | 7.6 mg/L | * |
04/07/2014 | 30 mg/dL | 3.8 mg/dL | 20 mm | 6.7 mg/L | * |
10/02/2014 | 26 mg/dL | 3.7 mg/dL | 10 mm | 8.0 mg/L | * |
12/18/2014 | 24 mg/dL | 3.5 mg/dL | 11 mm | 14.3 mg/L | * |
06/08/2015 | 26 mg/dL | 4.9 mg/dL | 12 mm | 15.1 mg/L | 2.4 UI/mL |
09/03/2015 | 23 mg/dL | 3.6 mg/dL | 16 mm | 15.1 mg/L | 6.1 UI/mL |
6.1 UI/mL | 26 mg/dL | 2.5 mg/dL | 33 mm | 15.9 mg/L | 6.2 UI/mL |
12/30/2015 | 24 mg/dL | 2.5 mg/dL | * | * | 8.6 UI/mL |
04/06/2016 | 26 mg/dL | 3.7 mg/dL | 35 mm | 18.6 mg/L | 7.7 UI/mL |
11/07/2016 | 25 mg/dL | 3.7 mg/dL | * | * | 5.5 UI/mL |
06/01/2017 | 73 mg/dL | 14.4 mg/dL | * | * | * |
09/13/2017 | 120 mg/dL | 15.1 mg/dL | 31 mm | 7.5 mg/L | * |
CC3: Complement C3, RR: 79-152 mg/dL; CC4: Complement C4, RR: 16.0-38.0 mg/dL; ESR: Erythrocyte sedimentation rate, RR: < 20 mm; CRP: C-Reactive protein, RR: < 6.0 mg/L; RF: Rheumatoid factor, RR: < 14.0 UL/mL.